Search
Menu
Home
HTB
2019
January
21
21 January 2019
Contents
Editorial
21 January 2019: vol 20 no 1: Brexit and other complications…
Treatment access
BMJ survey reports lack of NHS planning for Brexit: impact on drug supplies unknown
BASHH, BHIVA, HIVPA and NHIVNA statement on a no-deal Brexit
UK-CAB statement on Brexit, HIV and access to medicines
Model predicts benefit of dolutegravir for all in sub-Saharan Africa outweighs risk
Guidelines
US adult HIV guidelines updated (Oct 2018)
Side effects
Are integrase inhibitors linked to weight gain? – an evidence review
Frailty in older HIV positive people: independent associations with serious morbidity and mortality
HIV prevention and transmission
NHS England doubles places on IMPACT PrEP study to 26,000
US CDC updates HIV rates in transgender people
UK annual HIV surveillance data published – full reports
Michigan State updates HIV disclosure laws to reflect impact of effective ART
Ageing and life expectancy
HIV is associated with higher biological age compared to chronological age
Other news
Activists announce alternative 2020 conference in Mexico City
On the web
Conference abstracts online
Chemsex: online resources
TAGline: Intellectual Property and Access
Influencing and monitoring PEPFAR country programmes
PDFs
21 January 2019 vol 20 no 1
HTB RSS
Early access
Long-acting CAB/RPV in people with suboptimal adherence: IMPALA study results at 48 weeks
17 July 2025
Potential for once-monthly oral PrEP using MK-8527
17 July 2025
Five doses a week could be a safe option for adults: crisis response to ART stock-outs
16 July 2025
5-on 2-off dosing is inferior to continuous ART in BREATHER Plus – but no difference in clinical outcomes
16 July 2025
All early access reports
Current issues
July 2025
June 2025
May 2025
Back issues
Special report
AIDS quilts at the Tate: reflection and also anger
8 July 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate